FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30005511000001109: Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1737201000001118 Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1737221000001113 Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Is a Pembrolizumab 50mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has specific active ingredient Pembrolizumab false Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Is a Keytruda true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has active ingredient Monoclonal antibody true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has specific active ingredient Pembrolizumab true Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial Has AMP True Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start